Brokerages Set Immunovant, Inc. (NASDAQ:IMVT) Price Target at $31.11
Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the eleven ratings firms that are covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation, six have assigned a buy recommendation and one has issued […]
20 Feb 03:00 · The Cerbat Gem